Steven D. Rhodes

1.9k total citations
53 papers, 1.3k citations indexed

About

Steven D. Rhodes is a scholar working on Neurology, Molecular Biology and Rheumatology. According to data from OpenAlex, Steven D. Rhodes has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 21 papers in Molecular Biology and 14 papers in Rheumatology. Recurrent topics in Steven D. Rhodes's work include Neurofibromatosis and Schwannoma Cases (26 papers), Sarcoma Diagnosis and Treatment (10 papers) and Bone Tumor Diagnosis and Treatments (10 papers). Steven D. Rhodes is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (26 papers), Sarcoma Diagnosis and Treatment (10 papers) and Bone Tumor Diagnosis and Treatments (10 papers). Steven D. Rhodes collaborates with scholars based in United States, China and United Kingdom. Steven D. Rhodes's co-authors include Viola Vaccarino, Jerome L. Abramson, David G. Harrison, Arshed A. Quyyumi, Salman Ashfaq, Dean P. Jones, W. Craig Hooper, William S. Weintraub, Feng‐Chun Yang and Xianlin Yang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Genes & Development.

In The Last Decade

Steven D. Rhodes

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven D. Rhodes United States 17 521 288 158 147 144 53 1.3k
Shenghan Chen China 18 551 1.1× 138 0.5× 142 0.9× 90 0.6× 107 0.7× 33 1.6k
He Wu China 20 601 1.2× 699 2.4× 134 0.8× 93 0.6× 139 1.0× 46 1.6k
Arantxa Ortega‐Aznar Spain 19 676 1.3× 416 1.4× 114 0.7× 137 0.9× 150 1.0× 27 1.7k
Keisuke Ishizawa Japan 21 495 1.0× 523 1.8× 131 0.8× 48 0.3× 283 2.0× 94 1.7k
Gökhan Yılmaz Türkiye 13 488 0.9× 217 0.8× 95 0.6× 65 0.4× 97 0.7× 29 1.9k
Pascale de Lonlay France 26 685 1.3× 229 0.8× 132 0.8× 43 0.3× 191 1.3× 71 2.0k
Le Zhang China 18 390 0.7× 102 0.4× 225 1.4× 58 0.4× 170 1.2× 53 1.0k
Rosita Stanzione Italy 23 574 1.1× 68 0.2× 68 0.4× 68 0.5× 147 1.0× 65 1.5k
Anna Peñalba Spain 23 633 1.2× 428 1.5× 86 0.5× 144 1.0× 291 2.0× 68 1.8k
Shinong Wang United States 21 1.1k 2.1× 59 0.2× 109 0.7× 121 0.8× 195 1.4× 28 2.2k

Countries citing papers authored by Steven D. Rhodes

Since Specialization
Citations

This map shows the geographic impact of Steven D. Rhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven D. Rhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven D. Rhodes more than expected).

Fields of papers citing papers by Steven D. Rhodes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven D. Rhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven D. Rhodes. The network helps show where Steven D. Rhodes may publish in the future.

Co-authorship network of co-authors of Steven D. Rhodes

This figure shows the co-authorship network connecting the top 25 collaborators of Steven D. Rhodes. A scholar is included among the top collaborators of Steven D. Rhodes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven D. Rhodes. Steven D. Rhodes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukkes, Jodi L., M. Sullivan, Nathan Cunningham, et al.. (2025). A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/– mice. Journal of Clinical Investigation. 135(13). 1 indexed citations
2.
Liu, Sheng, Jun Wan, Steven P. Angus, et al.. (2025). PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway–Deficient Acute Myeloid Leukemia. Cancer Research Communications. 5(4). 648–667. 1 indexed citations
3.
Zhou, Zhuan, Chunhui Jiang, Waylan Bessler, et al.. (2025). TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma. Science Advances. 11(25). eadu0772–eadu0772. 1 indexed citations
4.
Stieglitz, Elliot, Alex G. Lee, Steven P. Angus, et al.. (2024). Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group. Cancer Discovery. 14(9). 1590–1598. 4 indexed citations
5.
Stieglitz, Elliot, Alex Lee, Steven P. Angus, et al.. (2023). Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: A Report from the Children's Oncology Group. Blood. 142(Supplement 1). 74–74. 2 indexed citations
6.
Rhodes, Steven D., Frank McCormick, Ross Cagan, et al.. (2023). RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights. Journal of Investigative Dermatology. 143(8). 1358–1368. 2 indexed citations
7.
Rhodes, Steven D., et al.. (2023). Giant hyperferroelectricity in LiZnSb and its origin. Physical review. B.. 107(9). 2 indexed citations
8.
Staedtke, Verena, Piotr Topilko, Lu Q. Le, et al.. (2023). Existing and Developing Preclinical Models for Neurofibromatosis Type 1−Related Cutaneous Neurofibromas. Journal of Investigative Dermatology. 143(8). 1378–1387. 5 indexed citations
9.
Ly, Ina, Carlos G. Romo, Kristen M. Kelly, et al.. (2023). Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas. Journal of Investigative Dermatology. 143(8). 1388–1396. 6 indexed citations
10.
Rhodes, Steven D., et al.. (2023). Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas. Current Oncology Reports. 25(5). 531–537. 6 indexed citations
11.
Rhodes, Steven D., Edina Komlódi-Pásztor, Meena Upadhyaya, et al.. (2023). Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials. Clinical Trials. 21(1). 40–50. 1 indexed citations
12.
Rhodes, Steven D., et al.. (2020). Brain Death Secondary to Rocky Mountain Spotted Fever Encephalitis. Case Reports in Critical Care. 2020. 1–5. 3 indexed citations
13.
Rhodes, Steven D., Waylan Bessler, Shi Chen, et al.. (2019). Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice. PMC. 2 indexed citations
14.
Wu, Colleen, Erinn B. Rankin, Laura Castellini, et al.. (2015). Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. PMC. 1 indexed citations
15.
Rhodes, Steven D., Hao Yang, K.M.J. Menon, et al.. (2015). Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis. PMC. 1 indexed citations
16.
Li, Yan, Wen Xing, Yongzheng He, et al.. (2014). Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice. PMC. 2 indexed citations
17.
Sharma, Richa, Xiaohua Wu, Steven D. Rhodes, et al.. (2013). Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice. Human Molecular Genetics. 22(23). 4818–4828. 52 indexed citations
18.
Kimura, Tomohiro, Alexei Yeliseev, Steven D. Rhodes, et al.. (2011). Recombinant Cannabinoid Type 2 Receptor in Liposome Model Activates G Protein in Response to Anionic Lipid Constituents. Journal of Biological Chemistry. 287(6). 4076–4087. 34 indexed citations
19.
Zhang, Wei, Steven D. Rhodes, Liming Zhao, et al.. (2011). Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. Bone. 48(6). 1378–1387. 28 indexed citations
20.
Abramson, Jerome L., Dean P. Jones, Salman Ashfaq, et al.. (2006). The FORT test: Reply to Dr Harma and colleagues. Atherosclerosis. 187(2). 443–444. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shenghan Chen Breakdown of academic impact, for papers by He Wu Breakdown of academic impact, for papers by Arantxa Ortega‐Aznar Breakdown of academic impact, for papers by Keisuke Ishizawa Breakdown of academic impact, for papers by Gökhan Yılmaz Breakdown of academic impact, for papers by Pascale de Lonlay Breakdown of academic impact, for papers by Le Zhang Breakdown of academic impact, for papers by Rosita Stanzione Breakdown of academic impact, for papers by Anna Peñalba Breakdown of academic impact, for papers by Shinong Wang
Rankless by CCL
2026